News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Patheon Completes Sale of Niagara-Burlington Commercial Manufacturing Business
February 1, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TORONTO, Feb. 1 /CNW/ - Patheon Inc. (TSX: PTI) today announced that it has completed the previously announced sale of its Niagara-Burlington commercial manufacturing business to Pharmetics Inc., under the same terms as previously disclosed.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
MORE ON THIS TOPIC
Bankruptcy
Bankrupt Sangamo offloads assets to Lilly, PTC in $161M sale
August 13, 2026
·
2 min read
·
Tristan Manalac
IPO
2026 IPO stock tracker: How newly public biotechs are performing
August 12, 2026
·
1 min read
·
Gabrielle Masson
Rare diseases
Sentynl bets up to $475M in licensing deal for Mereo’s rare lung disease asset
August 12, 2026
·
1 min read
·
Tristan Manalac
Mergers & acquisitions
Jazz commits up to $1.3B to buy Actio, bolster epilepsy pipeline
August 10, 2026
·
2 min read
·
Gabrielle Masson